Atrandi Biosciences Secures Funding
Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology VILNIUS, Lithuania and DENVER, CO, March 23, 2023 - Backed by international investors, Atrandi Biosciences is establishing a direct
Droplet Genomics Appoints Andy Watson as Board Chair
Vilnius, Lithuania; February 14, 2023:
Droplet Genomics, an emerging innovator and provider of microfluidic and single cell analysis technologies, announced today the appointment of Andy Watson as its Chairman of the Board of Directors.
“We are delighted...
LabGene and Droplet Genomics Join Forces to Accelerate Microfluidic Discoveries in Switzerland
Droplet Genomics, a leading provider of innovative microfluidic solutions, is excited to announce that it has signed Labgene as its new distributor in Switzerland. This collaboration between two industry leaders will bring Droplet Genomics' innovative...
Exhibiting at the Festival of Genomics & Biodata
Dear Attendees,
We are pleased to inform you that we will be participating in The Festival of Genomics & Biodata, to be held on January 25-26 at the Business Design Centre. Our booth, number TT8, will be located in the foyer outside the Main Stage and...
Fluorescence Assays Dominate Life Science Research
Drug screening long involved making a compromise between obtaining functional information and paying for it with low throughput, or settling for limited affinity information but in high throughput.
High-throughput functional screening (HTS) has solved...